De novo designed proteins modulate GPCR signalling in the dopamine D1 receptor
Researchers designed four protein exoframe modulators targeting the transmembrane region of the dopamine D1 receptor. Structural studies and functional assays showed agonist-positive, negative and biased allosteric modulation; an agonist-positive modulator restored activity in loss-of-function receptor mutants. The journal abstract supports these receptor-level experiments, rather than a clinical treatment claim.
Technology: Computational de novo protein design (AI-based protein design pipeline)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Structural and functional investigation of four designed modulators of the D1 receptor, including rescue of loss-of-function mutants.
- Still unknown: Review limited to abstract, online date and affiliations. Therapeutic efficacy in patients is not established by these receptor experiments.
- AI role: A deep-learning, hallucination-like protein-design workflow used structural prompts to generate transmembrane binding modes.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A%2210.1038%2Fs41586-025-09957-1%22&resultType=core&format=json
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 4/5 · Validation 3/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.